Keyword: Food and Drug Administration (FDA)

Plant Construction & Process Technology

Interoperability in the Pharma Supply Chain

25.01.2012 - Framework - When asked, most people say that they believe regulations should avoid dictating specific technologies but instead should dictate desired outcomes and let industry...

Plant Construction & Process Technology

Non-compliance is on the Rise

19.10.2011 - Steady Increase - All who follow industry trends will have noticed an increase in regulatory actions related to non-compliance issues. We can see this in the increased issuance of...

Plant Construction & Process Technology

API Sourcing in China and India

19.10.2011 - Paradigm Shift - The number of API manufacturers in India and China focused on supplying active ingredients to regulated markets has grown considerably over the past few years...

Research / Laboratory

Next-Generation Instrument Simplifies Sample Preparation

- Hamilton Bonaduz is introducing the Microlab 600, the next generation of semi-automated laboratory diluters and dispensers for sample preparation. Based on Hamilton's leading...

News

Biofuel Maker Solazyme Shares Rise in Nasdaq Debut

30.05.2011 - Shares of biofuel maker Solazyme Inc rose 15% in their stock market debut on Friday after the company's IPO raised more than expected. South San Francisco-based Solazyme uses algae...

News

Social Media and Networking in the Life Science Industry

09.05.2011 - Social media and social networking are at the forefront for many industries, and the life sciences industry is no different. George Ng, a partner at Gordon & Rees LLP, highlights...

News

FDA Chemist May Be Seeking Plea in Trading Case

18.04.2011 - The U.S. Food and Drug Administration chemist charged with using inside information to reap stock market profits may be seeking a plea deal, according to a letter filed in court on...

News

The EFCG is Pushing Its Agenda Forward During Complex Times

14.04.2011 - Tony Scott credits Hovione CEO Guy Villax with coining the phrase, "saints and sinners" when referring to the notoriously uneven playing field in the world of API and excipient...